Sitemap

Pages

• 2016 CME4HD Agenda
• 2CARE
• About Clinical Trials
• About HSG
  • HSG Blog
  • Our Accomplishments
  • Our Annual Meeting
    • HSG 2015 | Tampa Florida
    • HSG 2016 | Nashville TN
    • HSG 2017 | Denver CO
    • New Member Scholarship Application
    • Shoulson Scholar Fund Application
    • Submit an Abstract
    • UHDRS Symposium
  • Our Leadership
    • Executive Committee
    • HSG Board
    • HSG Staff
    • Working Groups
  • Our Partners
  • Our Services
    • Research Advisory Board
• Activate
• Activity
• All HSG Trials and Studies
• atest
• Care Education Videos
• Chair Job Description
• CME4HD
• CME4HD Agenda
• CME4HD Flyer
• CME4HD Invitation
• CME4HD Older Content
• CME4HD Online
• Co-Chair Job Description
• Contact
• Contact form test
• Contact Me About Future Research
• Coordinator Scholarship Form
• Credentialed Member Renewal
• CREST-E
• Current HSG Research Trials & Studies
  • KINECT-HD
  • KINECT-HD About Clinical Studies
  • KINECT-HD FAQs
  • KINECT-HD: About HD
  • Legato-HD Trial
    • LEGATO-HD Participating HSG Research Sites
  • Pride-HD Study
  • SIGNAL Trial
    • FAQ: SIGNAL Trial
    • SIGNAL News Feed
    • SIGNAL Participating HSG Research Sites
• Disclaimer of Medical Advice
• Education
• Exhibitor Information
• Exhibitor Terms
• Explore Denver Scavenger Hunt
• Family Education Day Houston (older)
• Find an HSG Research Site
  • HSG Credentialed Research Sites
• First-HD ARC-HD
• Groups
• HD Care Improvement Project
• HD Drug Pipeline
• HD Insights Archive
• HD Insights Podcast
• HD Insights Vol. 13
• HD Insights Volume 14
• HD Insights Volume 15
• HD Insights Volume 16
• HD Insights: Volume 1
• HD Insights: Volume 10
• HD Insights: Volume 11
• HD Insights: Volume 12
• HD Insights: Volume 12
• HD Insights: Volume 13
• HD Insights: Volume 17
• HD Insights: Volume 2
• HD Insights: Volume 3
• HD Insights: Volume 4
• HD Insights: Volume 5
• HD Insights: Volume 6
• HD Insights: Volume 7
• HD Insights: Volume 8
• HD Insights: Volume 9
• HD Treatment and Educational Resources
• HD-NET
• HDCIP Partners
• Home
• HSG 2016 Agenda Overview
• HSG 2016 Feedback Survey
• HSG 2016 Feedback Survey Success
• HSG 2016 Funded List
• HSG 2016 Hotel Lodging Reimbursement Form
• HSG 2016 Registration
• HSG 2016 Registration
• HSG 2016 Registration Success
• HSG 2017 Abstract Lay Summaries
• HSG 2017 Agenda
• HSG 2017 Floor Plans
• HSG 2017 Funded List
• HSG 2017 HD Family Education Day Scholarship
• HSG 2017: Elevating HD
• HSG 2018 Agenda
• HSG 2018 Funded List
• HSG 2019 – Family Day
• HSG 2019: Navigating HD
• HSG 2020
• HSG Blog
• HSG Careers
• HSG COI Guidelines
• HSG Credentialed Sites
• HSG Family Education Day – 2018 HOUSTON
• HSG Family Education Day – Houston 2018
• HSG Site Intuitional Agreement
• HSG Travel Policy
• Huntington’s Disease Center of Excellence at USF
• I am the DIFFERENCE
• I am the DIFFERENCE stories
• Investigator Materials Uploads
• Join HSG
  • Apply for HSG Investigator
  • Apply for HSG Site Coordinator
  • Become an HSG Member
    • Associate Member Application
    • Member Application
  • Become an HSG Research Site
  • HSG Credentialing
    • HSG Credentials Transfer
• KINECT-HD Study Locations
• Living with HD
  • Connect to the HD Community
  • HD Basics
  • HD Glossary
  • HD Myths & Facts
• Managing Huntington disease in the 21st Century
• Maps 2
• Members
• Neurodegenerative Disorders Research
• new map test
• News
• Our Story
• Past HSG Research Trials & Studies
• Potential HSG Research Site Questionnaire
• Potential Site Coordinator Questionnaire
• Potential Site Investigator Questionnaire
• Pride-HD
• Privacy Statement
• PROOF-HD
• PROOF-HD FAQ
• PROOF-HD Study Locations
• PROOF-HD-AL
• PROOF-HD-ES
• PROOF-HD-IT
• PROOF-HD-PL
• Register
• Seed Fund Projects
• SIGNAL TEST
• Site Coordinator Materials Upload
• Sitemap
• Sponsor The HSG Annual Meeting
• Sponsorship code backup
• Subscribe to HD Insights
• Support Us
• Survey
• Terms of Use
• Tools + Resources
  • Applications + Forms
  • HD Insights
    • Editorial Board Members
    • Publication Staff
  • HSG Research
  • UHDRS^TM
    • UHDRS Request Form
    • UHDRS Request Form
• UHDRS Symposium lodging request

Posts by category

• Category: Blog
  • Huntington Study Group Announces A Partnership with Prilenia Therapeutics to Conduct A Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease
  • Huntington Study Group Launches New CME Accredited Interactive Case Study Courses
  • HSG Announces Virtual Annual Meeting in 2020
  • Publication of Clinical Guidelines for Physical Therapy in Huntington Disease
  • Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease
  • Huntington Study Group Spotlighted on Rochester, NY Television
  • Huntington Study Group Achieves 100th Credentialed Research Site Milestone
  • The Huntington Study Group Announces New Education Committees
  • HSG Announces Location for 2019 Annual Meeting
  • HD Insights – Autumn Issue
  • Dr. Nicolò Zarotti Named Recipient of the Peter Como Scholarship
  • HSG Scholarship Winners Receive Funding to Attend Premier Huntington’s Disease Conference
  • Huntington Study Group Welcomes New Leadership May 1
  • New HD Insights Is Out (Vol. 19)
  • Career Opportunity: Clinical Fellowship in Huntington Disease Research at UBC
  • HSG Leadership Election Results
  • 2018 HSG Election
  • Ionis and Roche announce promising news on the Ionis-HTTRx trial
  • Loss of our friend, Dr. Kimberly Quaid de Cordon
  • Welcome new staff member, members of leadership team
  • We need you!
  • Seeking Survey Participants
  • World Experts in HD to Convene in Nashville
  • Registration for HSG 2016 is now open
  • JAMA publishes results of First-HD trial
  • Vaccinex Receives FDA Fast Track Designation for VX15 Antibody for the Treatment of Huntington’s Disease
  • What is HSG?
  • HSG adds board member Joni Steinman
  • Sleep disturbances are among the earliest non-motor symptoms in HD
  • HSG 2016: Call for Abstracts
  • Opportunity for fellowship in Regulatory Science
  • FDA wants to hear from you!
  • Why participating in clinical trials is important to Katie
  • Continuing education opportunity in Tampa, FL
  • Life Interrupted
  • What HSG Means to Jenna
  • What HSG Means to Martha
  • What HSG Means to Julie
  • What HSG Means to Claudia
• Category: Events
  • HSG 2015 Evening Blog: Enroll-HD
  • Regional Health Care Practitioners Invited to Learn More about Huntington Disease Oct. 23
  • LATE-BREAKING: More Scholarships Available for HSG 2015
  • HSG 2015 HD Family Education Day
  • Registration is open for HSG 2015: Building Our Future
  • CLOSED: Call for Abstracts: 9th Annual HD Clinical Research Symposium
  • Apply for a New Member Scholarship
  • Apply to be a Shoulson Scholar
  • An Interview with Dr. Nancy Wexler: Discovering the Huntington Disease Gene
  • Category: HSG 2016
    • Apply now for a scholarship for HSG 2016
• Category: HD Insights
  • HD Insights Volume 17 (PDF)
  • FDA approves deutetrabenazine (AUSTEDO™) to treat chorea
  • Meet the Scientist : Beverly Davidson
  • Game-changing gene-silencing therapies for HD
  • Research Round-Up
  • Highlights of CHDI
  • HD Research Around the World: Brazil
  • Highlights from the Journal of HD
  • Editor’s Letter
  • HD Insights Volume 16 (PDF)
  • 2016: Advances and Challenges in HD Therapeutic Development
  • Brief report: Pfizer Amaryllis trial ends: negative results lead to termination of extension study
  • Highly Cited HD Research
  • Research Round-Up
  • MEET THE COMPANY: uniQure
  • MEET THE SCIENTIST: Pavlina Konstantinova, MSc, PhD
  • MEET THE COMPOUND: AMT-130
  • Highlights from the Journal of HD
  • Thank you to Teva Pharmaceuticals
  • Highlights of HSG 2016: Discovering Our Future
  • Thank you to Raptor
  • Editor’s Letter
  • Job Opportunity: Deputy Editor, HD Insights
  • HD Insights Volume 15 (PDF)
  • Finding balance in HD: The role of PIAS1 in protein homeostasis
  • Meet the Company: WAVE Life Sciences
  • Meet the Compounds: WVE-120101 and WVE-120102
  • Highlights from the Journal of Huntington’s Disease
  • Research Round-Up: Insights of the Year 2015-2016
  • Career Opportunity: Vice President, Global Specialty Development, NDD, Teva
  • Career Opportunity: Director/Sr. Director Global Specialty Development, Neurodegenerative Diseases, Teva
  • Meet the Next Generation
  • Editor’s Letter
  • HD Insights Volume 14 (PDF)
  • Meet the Investigator: Diana Rosas
  • Research Round-Up
  • Lifestyle and HD Management
  • Meet the Funder
  • Prion-like protein spread in neurodegenerative diseases of the CNS and development of therapeutic approaches
  • Highlights from the Journal of Huntington’s Disease
  • Highlights of CHDI
  • Editor’s Letter
  • HD Insights Volume 13 (PDF)
  • Highlights of HSG 2015
  • Genetic factors that modify clinical onset of HD
  • Meet the Partner
  • Antisense Oligonucleotides Enter Clinical Trials
  • Research Round-Up
  • Highly Cited HD Research
  • Editor’s Letter
  • HD Insights Volume 12 (PDF)
  • Meet the Next Generation
  • HD Highlights: 19th International Congress of Parkinson’s Disease and Movement Disorders
  • Meet the Compound: VX15/2503
  • Meet the CEO: Maurice Zauderer, PhD
  • Editor’s Letter
  • Research Round-Up: Insights of the Year 2014-15
  • HD Insights Volume 11 (PDF)
  • Meet the Attorney
  • Research Round-Up
  • Editor’s Letter
  • Update on HD Disease-Modifying Strategies on the Horizon
  • Unraveling the Cause of Dysfunctional Autophagy in HD
  • Teva acquires Auspex for $3.5 billion
  • Greasing the Huntington Disease Brain: Palmitoylation as a therapeutic target
  • Highlights from the 10th Annual HD Therapeutics Conference
  • HD Insights Volume 10 (PDF)
  • Editor’s Letter
  • Research Round-Up
  • First-HD Results Released
  • Meet the Investigator
  • Highlights of HSG 2014
  • Meet the Compound: Laquinimod
  • Research Round-Up: Insights of the Year 2013-2014 (In the Clinic)
  • Meet the CEO
  • Meet the Founder
  • Meet the Compound: RP103 (cysteamine bitartrate delayed-release)
  • Editor’s Letter
  • Research Round-Up: Insights of the Year 2013-2014 (In the Lab)
  • Meet the Company
  • Highlights from the EHDN 2014 Plenary Meeting
  • Research Round-Up: Insights of the Year 2013-2014 (In Imaging and Biomarkers)
  • Meet the Compound: Olesoxime (TRO19622)
  • Research Round-Up
  • Editor’s Letter
  • Repair-HD
  • HD Highlights of the 18th International Congress of Parkinson’s Disease and Movement Disorders
  • Largest HD Clinical Trial Halted
  • Meet the Investigator
  • Animal Models of HD
  • HD Insights Volume 9 (PDF)
  • HD Insights Volume 7 (PDF)
  • Meet the Investigator
  • PREDICTions: Using High-Performance Computing to Visualize the HD Brain
  • Meet the CEO
  • Editor’s Letter
  • Research Round-Up
  • Prana Releases Promising Results
  • Meet the Company
  • HD Research around the World: Canada
  • Meet the Compound: SD-809 (dutetrabenazine)
  • Highlights from the Huntington Study Group 2013 Annual Meeting and Clinical Research Symposium
  • Meet the Compound: Coenzyme Q10
  • Research Round-Up
  • Highlights from the 2013 World Congress on Huntington’s Disease
  • Selected by Chance: An Interview with Ralf Reilmann
  • Editor’s Letter
  • HD Research Around the World: France
  • HD Insights Volume 5 (PDF)
  • HD Insights Volume 8 (PDF)
  • HD Research Around the World: Australia
  • Meet the Company
  • Part of the Solution: An Interview with Rodrigo Osorio
  • Meet the Compound: PF-02545920
  • Meet the Investigator
  • Research Round-Up
  • Editor’s Letter
  • HD Insights Volume 4 (PDF)
  • Editor’s Letter
  • HD Research Around the World: Japan
  • Research Round-Up
  • Lundbeck: Building Hope for HD with Casa De Hogar
  • Meet the Compound: Huntexil
  • Meet the Investigator
  • Meet the Company
  • HD Insights Volume 6 (PDF)
  • HD Insights Volume 3 (PDF)
  • Meet the Company
  • Research Around the World: Chile
  • Highlights from the CHDI HD Therapeutics Conference
  • The Use of Antisense Oligonucleotides for Gene Silencing
  • Research Round-Up
  • HD Insights Volume 2 (PDF)
  • Meet the Journal
  • Highlights from the 2011 Huntington Study Group Meeting
  • Research Round-Up
  • Inside the NINDS with Dr. Walter Koroshetz
  • HD Insights Volume 1 (PDF)
  • How Many People Have Huntington Disease?
  • Highlights from the World Congress on HD
  • Meet the Company
  • Research Round-Up
  • Meet the Investigator
  • Editor’s Welcome
• Category: HSG 2015
  • HSG 2015 Round-Up: Innovation
  • HSG 2015 Round-Up: Community
  • HSG 2015 Round-Up: Education
  • HSG Evening Blog: We Love Our Families
  • HSG Evening Blog: I’ve been here before, and I need to know what’s new
  • HSG 2015 Evening Blog: One Touch Stockings, Social Workers, and Summer Camp
• Category: I am the DIFFERENCE
  • Help4HD Blog Radio features I am the DIFFERENCE campaign
  • Lauren Holder: I am the DIFFERENCE
  • Katrina Hamel: I am the DIFFERENCE
  • Katie Jackson: I am the DIFFERENCE
  • Chris O’Brien: I am the DIFFERENCE
  • Cory Sargent: I am the DIFFERENCE
  • Rusty and Theresa: I am the DIFFERENCE
  • Ann and David Nelson: I am the DIFFERENCE
• Category: News
  • HSG Announces Launch of CME4HD 2019 – Accredited Online Education Platform
  • Overnight Switch from Tetrabenazine to Deutetrabenazine Safe, Trial Shows
  • FDA Approves Second Drug for Huntington Disease Symptom
  • Chorea Reduced by Deutetrabenazine in Study led by HSG
  • FDA Requests More Data on Potential New Treatment for Huntington Disease
  • Show off your credentials
  • SIGNAL completes enrollment in cohort A
• Category: Press Releases
  • Announcing HSG’s 2015 Award Winners
  • Teva Press Release: April 24, 2014
  • Teva & Active Biotech Press Release: November 4, 2014
  • Auspex Press Release: December 16, 2014
  • HSG Press Release: October, 2014
  • HSG Press Release: August 8, 2014
  • HSG Press Release: September 2012
  • HSG Press Release: May 14, 2009
  • HSG Press Release: December 2, 2008

CM Tooltip Glossary

• Antibody
• Non-Physician Policy
• Zinc-finger Nucleases
• YAC
• YAC128
• Vesicle
• Ventricle
• Vascular System
• Uterus
• Trinucleotide Repeat
• Transgenic
• Transcriptional Regulation
• Transcriptional Dysregulation
• Transcription Factor
• Transcription
• Transcranial Magnetic Stimulation
• TR-FRET
• Total Functional Capacity
• Therapeutics
• Synapse
• Synaptophysin
• Synaptic transmission
• Suprachiasmatic Nucleus
• Stem Cells
• Statistically Significant
• Splicing
• Spinocerebellar Ataxia
• Soma
• Sodium
• siRNA
• Single Nucleotide Polymorphisms
• Significance Testing
• Sense Strand
• SCA
• SBMA
• SAHA
• Ryanodine Receptor
• Ro 61-8048
• RNA Interference
• RNA
• Ribosome
• Rhes
• Reduced Penetrance Allele
• Recombinant
• Receptor
• Rabies
• R6/2
• Quinolinic Acid
• Putamen
• Pluripotency
• Primate
• Promoter
• Prion
• Prevalence
• Prenatal Testing
• Pre-implantation Genetic Diagnosis
• Post-translational Modification
• PolyQ
• Polymerase Chain Reaction
• Placenta
• Placebo
• Pineal
• Phosphodiesterase
• Phosphatase
• Phenylbutyrate
• Phase III
• Perseveration
• Peptides
• PDE10
• Parkinson's Disease
• PACSIN
• Open Label
• Observational
• Nucleus
• Nucleotide Bases
• Non-disclosure
• Neutron
• Neuroprotection
• Neuron
• Neurodegenerative
• N-Terminal Fragment
• multiple sclerosis
• Motor Neuron Disease
• Mitochondria
• Microglia
• Microdialysis
• methionine
• metabolism
• meta-analysis
• messenger RNA
• Mesenchmal
• Melatonin
• medium spiny neuronmedium spiny neurons
• magnetic resonance
• longitudinal study
• leptin
• kynurenine
• kynurenic acid
• knockout
• knock-in
• KMO
• kinase
• juvenile HD
• JM6
• intracranial volume
• interventional
• intermediate alleles
• intermediate allele
• insulin
• inflammation
• induced pluripotent stem cells
• In vitro fertilization
• hypothalamus
• Hydrophobic
• Hydrophilic
• huntingtin protein
• HTTAS
• HTT
• hormone
• histone
• hippocampus
• heat shock response
• HDAC
• growth factor
• glutamine
• glutamate
• Genome Editing
• genome
• genetic engineering
• gene silencing
• GDNF
• Ganglioside
• GABA
• frontotemporal dementia
• fetus
• expression profiling
• exosome
• exclusion testing
• excitotoxic
• ependymal cells
• enteric nervous system
• Endoplasmic Reticulum
• embryo
• efficacy
• dystonia
• dopamine
• DNA fingerprinting
• differentiate
• dendritic cell
• deep brain stimulation
• cytoplasm
• cytokine
• Cyclic-GMP
• Cyclic-AMP
• CSF
• cross-sectional study
• cohort
• coenzyme-Q10
• circadian
• cilia
• chromosomes
• chorionic villus sampling
• Chaperone
• Cervix
• CED
• Caspase inhibitor
• Caffeine
• Bone marrow
• Blood-brain barrier
• Biomarker
• BDNF
• BACHD
• BACE1
• BAC
• Axon
• ASOs
• Apoptosis
• Antioxidant
• Anti-sense
• Amyloid
• Amygdala
• Amino acid
• Alpha-1 (also known as alpha-1-antitrypsin)
• Allele
• aggregate (also known as aggregates)
• Acetyl
• AAV
• Symptomatic
• Recessive
• Presymptomatic
• Personality changes
• Psychiatric disturbances
• Neurodegenerative
• Hereditary
• Genetic testing
• Dominant
• Dementia
• Chorea
• CAG Repeat
• Anticipation
• At-risk